https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48300 Tue 14 Mar 2023 14:13:43 AEDT ]]> Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1727 Sat 24 Mar 2018 08:27:29 AEDT ]]> Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20121 Sat 24 Mar 2018 07:51:45 AEDT ]]> Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27000 50. A Cox multivariate regression model for LFS retained both B-other ALL subtype (hazard ratio 4·1, P = 0·0062) and MRD persistence post-HSCT (hazard ratio 3·9, P = 0·0070) as independent adverse prognostic variables. Persistent MRD could be used to direct post-HSCT therapy.]]> Sat 24 Mar 2018 07:25:49 AEDT ]]>